0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Cardiovascular Disease Risk Prediction Factors

Ken Williams, PStat; Howard M. Monroe, PhD
JAMA. 2012;308(19):1969. doi:10.1001/jama.2012.14042.
Text Size: A A A
Published online

Extract

To the Editor: The recent ERFC meta-analysis1 indicated that the standard hazard ratio (HR) for cardiovascular disease using baseline levels of non-HDL-C was 1.27 (95% CI, 1.22 to 1.33) vs 1.24 (1.19 to 1.29) using apolipoprotein B. In a head-to-head comparison, the HR for apolipoprotein B relative to the HR for non-HDL-C was lower: −2.4% (95% CI, −4.1% to −0.6%), assuming a correlation (r = 0.91) between the 2 markers.2 This contrasts with the within-study comparisons in our meta-analysis,2 which found the standard HR for coronary heart disease of apolipoprotein B averaged 5.7% (95% CI, 2.4% to 9.1%) higher than that of non-HDL-C. Our meta-analysis focused on HRs rather than the C statistic or the Cohen d statistic to aid assessment of the relative utility of each marker to target treatment rather than to just assess risk. Thus each meta-analysis estimated statistically significant associations in opposite directions with different but related outcomes. We wonder how there could be such a systematic difference in findings.

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

November 21, 2012
Allan D. Sniderman, MD, FRSC; Curt D. Furberg, MD, PhD
JAMA. 2012;308(19):1969. doi:10.1001/jama.2012.14049.
November 21, 2012
Emanuele Di Angelantonio, MD, PhD; Pei Gao, PhD; John Danesh, FRCP; for the Emerging Risk Factors Collaboration
JAMA. 2012;308(19):1969. doi:10.1001/jama.2012.14045.
CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Jobs
brightcove.createExperiences();